Lyra Therapeutics logo

Lyra Therapeutics

Innovative solutions for precise, localized treatments in ear, nose, and throat care.

51-200 employees · est. 2005

VS
Titan Pharmaceuticals logo

Titan Pharmaceuticals

33 employees · est. 1992 · South San Francisco, United...

Titan Pharmaceuticals is the older company (2005 vs 1992); Lyra Therapeutics is the larger of the two.

Side-by-Side Comparison

Lyra Therapeutics Titan Pharmaceuticals
Founded
2005 1992 older
Headquarters
Not tracked yet South San Francisco, United States
Employees
51-200 larger 33
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
$264.09M $54.20M
Funding Rounds
10 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Drug Delivery, Clinical-stage Therapeutics, Ear, Nose, And Throat Diseases, Localized Treatment, XTreo Technology Platform, Bioresorbable Polymeric Matrices, In-office Procedure, Continuous Drug Therapy, Sinonasal Passages, CRS Treatment, Mometasone Furoate, FDA-approved Drugs, Efficacy And Safety Profile Biopharmaceutical, Drug Delivery System, Opioid Dependence Treatment, FDA Approval, Continuous Blood Levels, ProNeura Technology, Sustained Medication Delivery, Braeburn Pharmaceuticals Partnership, Probuphine, Chronic Conditions Treatment, Parkinson's Disease, Hypothyroidism, Medical Outcomes, Proprietary Therapeutics, Commercialization
Website
lyratherapeutics.com titanpharm.com
Lyra Therapeutics logo

About Lyra Therapeutics

Lyra Therapeutics, Inc. is a biotechnology company founded in 2005, specializing in innovative drug and delivery solutions for ear, nose, and throat diseases. Using its proprietary XTreo technology platform, Lyra ensures precise and consistent medication delivery directly to affected tissues for ext...

Titan Pharmaceuticals logo

About Titan Pharmaceuticals

Titan Pharmaceuticals is a U.S.-based company established in 1992. The company's focus lies in the development of proprietary therapeutics primarily targeting serious medical disorders, offering innovative solutions for unmet medical needs. Its flagship product, Probuphine®, marked a significant mil...

We will tell you when either one moves

BounceWatch watches Lyra Therapeutics and Titan Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lyra Therapeutics and Titan Pharmaceuticals — by email.

Frequently Asked Questions

Lyra Therapeutics — Innovative solutions for precise, localized treatments in ear, nose, and throat care.. Titan Pharmaceuticals. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lyra Therapeutics has raised $264.09M while Titan Pharmaceuticals has raised $54.20M.
Lyra Therapeutics and Titan Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lyra Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Lyra Therapeutics on 12 Sep 2024, and Titan Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes